Viewing Study NCT02452632


Ignite Creation Date: 2025-12-24 @ 9:54 PM
Ignite Modification Date: 2026-04-12 @ 7:01 PM
Study NCT ID: NCT02452632
Status: COMPLETED
Last Update Posted: 2024-11-12
First Post: 2015-05-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin
Sponsor: Astellas Pharma Korea, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-06-22
Start Date Type: ACTUAL
Primary Completion Date: 2017-01-05
Primary Completion Date Type: ACTUAL
Completion Date: 2017-01-05
Completion Date Type: ACTUAL
First Submit Date: 2015-05-14
First Submit QC Date: None
Study First Post Date: 2015-05-22
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-11-08
Last Update Post Date: 2024-11-12
Last Update Post Date Type: ACTUAL